Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Final Hemophilia Drug Policies .

print Print Back Back Hemophilia Products - Factor VIII Prior Authorization Program Summary Policy Number:...

print Print Hemophilia Products - Anti-Inhibitor Coagulant Complex: Feiba NF/Feiba VF Policy Number: PH-0337 Intravenous Last Review Date: 06/01/2023 Date of Origin:...

Tretten

Alphanine SD, Alprolix, BeneFIX, Idelvion, Ixinity, Mononine, Profilnine, Rebinyn, and Rixubis

Advate, Adynovate, Afstyla, Eloctate, Hemofil M, Koate DVI, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Obizur, Recombinate, Xyntha/Xyntha Solofuse, Jivi, Esperoct, Altuviiio

Coagadex

Corifact

NovoSeven RT, Sevenfact

Vonvendi

Alphanate, Humate-P, Wilate

Hemlibra

Hympavzi